VVOS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 125736 min ago

@ $5.07

Wydano: 9 vas. 2024 @ 21:03

Zwrot: -53.06%

Poprzedni sygnał: vas. 6 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: -21.03 %

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	103 589
Średni wolumen	184 130
Kapitalizacja rynkowa	7.10M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $-1.170 ) 2024-06-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.210
ATR14	$0.0140 (0.59%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-20	Huntsman Ronald Kirk	Buy	14 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	5 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	10 000	Common Stock
2023-06-15	Huntsman Ronald Kirk	Buy	21	Common Stock
2023-06-14	Huntsman Ronald Kirk	Buy	10 000	Common Stock

INSIDER POWER
100.00
Last 44 transactions
Buy: 1 747 856 \| Sell: 433 336

Wolumen Korelacja

Długi: -0.19 (neutral)

Krótki: -0.81 (strong negative)

Signal:(44.834) Neutral

Vivos Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje
RIDE	0.958
FFIE	0.956
EBIX	0.951
EVOK	0.945
VRAY	0.944
MSEX	0.942
ASLE	0.941
AEHR	0.939
VTNR	0.936
LMDX	0.935

10 Najbardziej negatywne korelacje
SGII	-0.955
SPLK	-0.947
EGLE	-0.944
INBKZ	-0.944
ADAL	-0.94
BRIV	-0.936
XM	-0.935
BSCO	-0.934
SFBC	-0.932
JUGG	-0.93

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vivos Therapeutics, Inc. Korelacja - Waluta/Towar

-0.49
( neutral )

-0.35
( neutral )

0.00
( neutral )

-0.48
( neutral )

-0.43
( neutral )

0.78
( moderate )

Vivos Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$13.80M
Zysk brutto:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2023
Przychody:	$13.80M
Zysk brutto:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2022
Przychody:	$16.02M
Zysk brutto:	$10.02M (62.52 %)
EPS:	$-24.62

FY	2021
Przychody:	$16.89M
Zysk brutto:	$11.87M (70.31 %)
EPS:	$-1.576

Financial Reports:

No articles found.

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.